FDA Takes Key Action by Approving Second COVID-19 Vaccine
Today (January 31, 2022), the U.S. Food and Drug Administration approved a second COVID-19 vaccine. The vaccine has been known as the Moderna COVID-19 Vaccine; the approved vaccine will be marketed as Spikevax for the prevention of COVID-19 in individuals 18 years of age and older.
FY14 Annual Report
The Annual Report includes an overview message of the prior fiscal year from the City Manager along with major accomplishments. For additional copies, contact Ini Tomeu, Public Information Officer at itomeu@cambridgema.gov.
Agassiz Neighborhood Study
Recommendations by a study committee composed of neighborhood residents working with CDD staff covering housing, land use and zoning, urban design, transportation, open space, institutional uses, and economic development.